Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting

ClinicalTrials.gov ID: NCT01808573

Public ClinicalTrials.gov record NCT01808573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A STUDY OF NERATINIB PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER WHO HAVE RECEIVED TWO OR MORE PRIOR HER2-DIRECTED REGIMENS IN THE METASTATIC SETTING (NALA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, multi-center, multinational, open-label, active-controlled, parallel design study of the combination of neratinib plus capecitabine versus the combination of lapatinib plus capecitabine in HER2+ MBC patients who have received two or more prior HER2 directed regimens in the metastatic setting.

Study identification

NCT ID
NCT01808573
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Puma Biotechnology, Inc.
Industry
Enrollment
621 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2013 (Actual)
Primary completion
Sep 28, 2018 (Actual)
Completion
Dec 9, 2019 (Actual)
Last update posted
Jun 11, 2021

2013 – 2019

United States locations

U.S. sites
79
U.S. states
18
U.S. cities
59
Facility City State ZIP Site status
Ironwood Cancer and Research Centers Chandler Arizona 85224 —
Ironwood Cancer and Research Centers Gilbert Arizona 95297 —
Ironwood Cancer and Research Centers Mesa Arizona 85206 —
Ironwood Cancer and Research Centers Scottsdale Arizona 85202 —
UCLA Hematology Oncology Alhambra California 91801 —
CBCC Global Research, Inc. at Comprehensive Blood and Caner Center Bakersfield California 93309 —
Compassionate Cancer Care Medical Group Inc. Fountain Valley California 92708 —
St. Jude Heritage Medical Group Fullerton California 92834 —
St. Jude Heritage Medical Group Fullerton California 92835 —
Marin Cancer Care, Inc. Greenbrae California 94904 —
UCLA Hematology Oncology Irvine California 92604 —
University of California San Diego Medical Center La Jolla California 92037 —
University of California San Diego Moores Cancer Center La Jolla California 92093-0698 —
Breastlink Medical Group, Inc. Orange California 92868 —
UCLA Hematology Oncology Pasadena California 91005 —
UCLA Hematology Oncology Porter Ranch California 91326 —
Emad Ibrahim, MD Redlands California 92373 —
Cancer Care Associates Medical Group, Inc Redondo Beach California 90277 —
Compassionate Cancer Care Medical Group Riverside California 92501 —
University of California San Diego Medical Center - Hillcrest San Diego California 92103 —
Sharp Memorial Hospital San Diego California 92123 —
Breastlink Medical Group, Inc. Santa Ana California 92705 —
Cancer Center of Santa Barbara Sansum Clinic Santa Barbara California 93105 —
Central Coast Medical Oncology Santa Maria California 93454 —
UCLA Hematology Oncology Santa Monica California 90404 —
Cancer Center of Santa Barbara Solvang California 93463 —
UCLA Healthcare Santa Clarita Oncology Valencia California 91355 —
UCLA Hematology/Oncology Westlake Village California 91361 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Broward Medical Oncology Office Plantation Florida 33313 —
Florida Cancer Research Institute Plantation Florida 33324 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory Clinic Atlanta Georgia 30322 —
Emory University Winship Cancer Institute Atlanta Georgia 30322 —
OnCare Hawaii Honolulu Hawaii 96813 —
Queen's Medical Center Honolulu Hawaii 96813 —
Straub Clinic and Hospital Honolulu Hawaii 96813 —
University of Hawaii Cancer Center Honolulu Hawaii 96813 —
Resurrection Medical Group Chicago Illinois 60057 —
North Shore Oncology-Hematology Associates, Ltd. Crystal Lake Illinois 60014 —
Primary Healthcare Associates, SC Harvey Illinois 60426 —
North Shore Hematology Oncology Highland Park Illinois 60035 —
North Shore Oncology-Hematology Associates, Ltd. Libertyville Illinois 60048 —
Orchard Healthcare Research Inc Skokie Illinois 60077 —
Primary Health Oncology Hobart Indiana 46342 —
St. Mary Medical Center Hobart Indiana 46342 —
Community Hospital Munster Indiana 46321 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore Maryland 21231 —
Sidney Kimmel Comprehensive Cancer Center at John Hopkins at Greenspring Station Lutherville Maryland 21093 —
The Cancer Institute at University of Maryland St. Joseph Medical Center Towson Maryland 21204 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Siteman Cancer Center - St. Peters City of Saint Peters Missouri 63376 —
Washington University in St. Louis St Louis Missouri 63110 —
Siteman Cancer Center - South County St Louis Missouri 63129 —
Siteman Cancer Center - West County St Louis Missouri 63141 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
North Shore Hematology Oncology Association PC East Setauket New York 11733 —
Clinical Research Alliance Lake Success New York 11042 —
NYU Langone Medical Center Lake Success New York 11042 —
Clinical Research Alliance, Inc. New York New York 10021 —
Weill Cornell Medical College New York New York 10065 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
University Hospitals Case Medical Center Orange Ohio 44122 —
UPMC Cancer Pavillion Greensburg Pennsylvania 15601 —
Hershey Medical Center Hershey Pennsylvania 17033 —
UPMC Cancer Pavillion Monroeville Pennsylvania 15146 —
Magee Women's Hospital Pittsburgh Pennsylvania 15213 —
UPMC Cancer Pavillion Pittsburgh Pennsylvania 15215 —
Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
UPMC Cancer Pavillion Pittsburgh Pennsylvania 15237 —
UPMC Cancer Pavillion Uniontown Pennsylvania 15401 —
UPMC Cancer Pavillion West Mifflin Pennsylvania 15122 —
West Clinic PC Germantown Tennessee 38138 —
West Clinic PC Memphis Tennessee 38120 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 173 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01808573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01808573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →